Giorgos D. Michalopoulos

Dr. Giorgos D. Michalopoulos

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBMohamad Bydon
Mohamad Bydon
WQWenchun Qu
Wenchun Qu
FMF. M. Moinuddin
F. M. Moinuddin
CHChristine L. Hunt
Christine L. Hunt
KGKristin L. Garlanger
Kristin L. Garlanger
ADAllan Dietz
Allan Dietz
: Intrathecal delivery of autologous culture-expanded adipose tissue-derived mesenchymal stem cells (AD-MSC) could be utilized to treat traumatic spinal cord injury (SCI). This Phase I trial (ClinicalTrials.gov: NCT03308565) included 10 patients with American Spinal Injury Association Impairment Scale (AIS) grade A or B at the time of injury. The study’s primary outcome was the safety profile, as captured by the nature and frequency of adverse events. Secondary outcomes included changes in sensory and motor scores, imaging, cerebrospinal fluid markers, and somatosensory evoked potentials. The manufacturing and delivery of the regimen were successful for all patients. The most commonly reported adverse events were headache and musculoskeletal pain, observed in 8 patients. No serious AEs were observed. At final follow-up, seven patients demonstrated improvement in AIS grade from the time of injection. In conclusion, the study met the primary endpoint, demonstrating that AD-MSC harvesting and administration were well-tolerated in patients with traumatic SCI.

12 August 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LCLoukas Chatzis
Loukas Chatzis
VPVasileios C. Pezoulas
Vasileios C. Pezoulas
FFFrancesco Ferro
Francesco Ferro
SGSaviana Gandolfo
Saviana Gandolfo
VDValentina Donati
Valentina Donati
AGAndreas Goules
Andreas Goules
Background: To compare the clinical, serological and histologic features between male and female patients with Sjögren’s syndrome (SS) and explore the potential effect of gender on lymphoma development. Methods: From a multicenter population (Universities of Udine, Pisa and Athens, Harokopion and Ioannina (UPAHI)) consisting of consecutive SS patients fulfilling the 2016 ACR/EULAR criteria, male patients were identified, matched and compared with female controls. Data-driven multivariable logistic regression analysis was applied to identify independent lymphoma-associated factors. Results: From 1987 consecutive SS patients, 96 males and 192 matched female controls were identified and compared. Males had a higher frequency of lymphoma compared to females (18% vs. 5.2%, OR = 3.89, 95% CI: 1.66 to 8.67; p = 0.0014) and an increased prevalence of serum anti-La/SSB antibodies (50% vs. 34%, OR = 1.953, 95% CI: 1.19 to 3.25; p = 0.0128). No differences were observed in the frequencies of lymphoma predictors between the two genders. Data-driven multivariable logistic regression analysis revealed negative association of the female gender with lymphoma and positive association with lymphadenopathy. Conclusion: Male SS patients carry an increased risk of lymphoma development. Although statistics showed no difference in classical lymphoma predictors compared to females, data-driven analysis revealed gender and lymphadenopathy as independent lymphoma-associated features.

1 May 2022 in Journal of Neurosurgery: Spine
Verified
Journal Article
Open access
PDF file
JMJames Mooney
James Mooney
GMGiorgos D. Michalopoulos
Giorgos D. Michalopoulos
MAMohammed Ali Alvi
Mohammed Ali Alvi
DZDaniel Zeitouni
Daniel Zeitouni
ACAndrew K. Chan
Andrew K. Chan
MBMohamad Bydon
Mohamad Bydon
OBJECTIVE: With the expanding indications for and increasing popularity of minimally invasive surgery (MIS) for lumbar spinal fusion, large-scale outcomes analysis to compare MIS approaches with open procedures is warranted. METHODS: The authors queried the Quality Outcomes Database for patients who underwent elective lumbar fusion for degenerative spine disease. They performed optimal matching, at a 1:2 ratio between patients who underwent MIS and those who underwent open lumbar fusion, to create two highly homogeneous groups in terms of 33 baseline variables (including demographic characteristics, comorbidities, symptoms, patient-reported scores, indications, and operative details). The outcomes of interest were overall satisfaction, decrease in Oswestry Disability Index (ODI), and back and leg pain, as well as hospital length of stay (LOS), operative time, reoperations, and incidental durotomy rate. Satisfaction was defined as a score of 1 or 2 on the North American Spine Society scale. Minimal clinically important difference (MCID) in ODI was defined as ≥ 30% decrease from baseline. Outcomes were assessed at the 3- and 12-month follow-up evaluations. RESULTS: After the groups were matched, the MIS and open groups consisted of 1483 and 2966 patients, respectively. Patients who underwent MIS fusion had higher odds of satisfaction at 3 months (OR 1.4, p = 0.004); no difference was demonstrated at 12 months (OR 1.04, p = 0.67). Lumbar stenosis, single-level fusion, higher American Society of Anesthesiologists Physical Status Classification System grade, and absence of spondylolisthesis were most prominently associated with higher odds of satisfaction with MIS compared with open surgery. Patients in the MIS group had slightly lower ODI scores at 3 months (mean difference 1.61, p = 0.006; MCID OR 1.14, p = 0.0495) and 12 months (mean difference 2.35, p < 0.001; MCID OR 1.29, p < 0.001). MIS was also associated with a greater decrease in leg and back pain at both follow-up time points. The two groups did not differ in operative time and incidental durotomy rate; however, LOS was shorter for the MIS group. Revision surgery at 12 months was less likely for patients who underwent MIS (4.1% vs 5.6%, p = 0.032). CONCLUSIONS: In patients who underwent lumbar fusion for degenerative spinal disease, MIS was associated with higher odds of satisfaction at 3 months postoperatively. No difference was demonstrated at the 12-month follow-up. MIS maintained a small, yet consistent, superiority in decreasing ODI and back and leg pain, and MIS was associated with a lower reoperation rate.

1 August 2019 in The American Journal of Surgery
Verified
Journal Article
Closed access
IDIlias P. Doulamis
Ilias P. Doulamis
GMGiorgos D. Michalopoulos
Giorgos D. Michalopoulos
VBVasileios Boikou
Vasileios Boikou
DSDimitrios Schizas
Dimitrios Schizas
ESEleftherios Spartalis
Eleftherios Spartalis
KEKonstantinos P. Economopoulos
Konstantinos P. Economopoulos

26 November 2022 in World Neurosurgery
Verified
Journal Article
Closed access
ZPZachariah Pinter
Zachariah Pinter
AMAnthony Mikula
Anthony Mikula
MSMatthew Shirley
Matthew Shirley
AXAshley Xiong
Ashley Xiong
GMGiorgos D. Michalopoulos
Giorgos D. Michalopoulos
ASArjun S. Sebastian
Arjun S. Sebastian

5 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBMohamad Bydon
Mohamad Bydon
WQWenchun Qu
Wenchun Qu
FMF. M. Moinuddin
F. M. Moinuddin
CHChristine L. Hunt
Christine L. Hunt
KGKristin L. Garlanger
Kristin L. Garlanger
ADAllan Dietz
Allan Dietz